Omics! Omics!

Tonight, of course, is Halloween, one of the many holidays which in the U.S. has a serious sweet tooth. After taking Version 2.0 around for...

Officially, I started this blog a year ago yesterday , with the first post about science coming the next day . At times, I wonder what posse...

One of the many attractions of the next generation sequencing techniques is that they eliminate the step of cloning in E.coli the DNA to be ...

G-protein coupled receptors, or GPCRs, are a key class of eukaryotic membrane receptors. Roughly 50% of all small molecule therapeutics tar...

Sometimes in life, you just want to lie back and stare at the ceiling. Other times, you have no choice, which is how I found myself for a w...

As the Harry Potter series went on, more and more of the characters' names telegraphed a key component of their properties. One of the ...

Last week's Science contained the p ublication of the Chlamydomonas reinhardtii genome , an old friend of mine from my undergraduate day...

Anyone interested in personal genomics should hunt down the new Nature (available online at the moment) and read the story of Hugh Rienhoff ...

I admire Richard Branson for his many entrepreneurial and adventuring efforts. I am especially wishing for the success of his spaceflight v...

For a number of years now I think of early October as Nobel season. With the prizes often come two rounds of silliness. The fun silliness a...

Visitors to our house are likely to quickly notice a recurrent theme in the decor, starting with a garden ornament and continuing throughout...

I had commented a while back that I was contemplating shifting my programming focus from Perl to another language. The existing code base ...

GenomeWeb carries the news that another little-known company, this time English, has thrown its hat into the Archon X-Prize ring . Base4 In...

I recently stumbled across a paper proposing a set of mammalian genomes for sequencing to further aging research. A free version of the pro...

A recent publication in Nucleic Acids Research (a very fine journal which is now all open-access) highlights an underappreciated (IMHO) asp...

Miss Amanda is quite excited about two new papers on the Nature Genetics preprint site, though as we don't have a subscription we're...

Sometimes soon after writing something I see something related to the post, but I've been lousy about doing anything about it. But this...

A huge area of drug discovery is targeting protein kinases. There are about 500 protein kinase-like proteins in the human proteome. Some o...

Today's GenomeWeb contained an item on yet another genome sequencing startup , Genome Corp (which was the name proposed for the first ge...

Today's GenomeWeb carried the news that Sequenom has licensed a bit of nanopore technology with the intent of developing a DNA sequence...